<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We investigated postischemic alterations in <z:chebi fb="13" ids="22720">benzodiazepine</z:chebi> receptor, D1 <z:chebi fb="40" ids="18243">dopamine</z:chebi> receptor, and muscarinic <z:chebi fb="9" ids="15355">acetylcholine</z:chebi> receptor binding after transient middle cerebral artery (<z:chebi fb="70" ids="34342">MCA</z:chebi>) occlusion in rats using [3H]-<z:chebi fb="0" ids="5103">flumazenil</z:chebi>, [3H]-SCH23390, and [3H]-N-<z:chebi fb="36" ids="29309">methyl</z:chebi>-4-piperidyl benzilate ([3H]-NMPB), respectively, as radioligand </plain></SENT>
<SENT sid="1" pm="."><plain>These ligand bindings were determined at 3 and 24 h and at 3 and 7 days after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion of <z:chebi fb="70" ids="34342">MCA</z:chebi> by using autoradiographic methods </plain></SENT>
<SENT sid="2" pm="."><plain>Ischemic cell injury was clearly detected from 3 h after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion and progressively increased from 3-24 h after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion of <z:chebi fb="70" ids="34342">MCA</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>The area of cell injury reached maximum at 24 h after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion of <z:chebi fb="70" ids="34342">MCA</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>[3H]-SCH23390 binding was reduced to 47% of the contralateral side at 3 days after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion of <z:chebi fb="70" ids="34342">MCA</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>After 7 days, [3H]-SCH23390 binding was further reduced by 20% in the striatum </plain></SENT>
<SENT sid="6" pm="."><plain>[3H]-NMPB binding was slightly decreased in both the striatum and cerebral cortex at 3 days after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion of <z:chebi fb="70" ids="34342">MCA</z:chebi>, and [3H]-NMPB binding in the striatum and cerebral cortex were reduced to 42 and 62% of the contralateral side at 7 days after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion of <z:chebi fb="70" ids="34342">MCA</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>[3H]-NMPB was also decreased at 24 h </plain></SENT>
<SENT sid="8" pm="."><plain>In contrast, [3H]-<z:chebi fb="0" ids="5103">flumazenil</z:chebi> binding was not decreased in the striatum and cerebral cortex within 7 days after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion of <z:chebi fb="70" ids="34342">MCA</z:chebi> </plain></SENT>
<SENT sid="9" pm="."><plain>These results suggest that [3H]-SCH23390 and [3H]-NMPB binding do not correlate with cell injury by <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion, although vulnerability to <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion was observed with these receptors </plain></SENT>
<SENT sid="10" pm="."><plain>In addition, central <z:chebi fb="13" ids="22720">benzodiazepine</z:chebi> receptor imaging might be essentially stable to neuronal cell injury induced by transient focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in rats, in contrast to the results of PET studies </plain></SENT>
</text></document>